Lipid nanoparticle encapsulated membrane-anchored E2 mRNA vaccine elicits cross-protective immune responses against bovine viral diarrhoea virus infection in calves
Authors:
Abstract
No abstract availableKeywords
Funding Information
- National Key Laboratory Foundation of China
- National Key Research and Development Program of China (2023YFD1801303)
- Natural Science Foundation of Heilongjiang Province (JQ2021C005)
This publication has 52 references indexed in Scilit:
- Novel bovine viral diarrhea virus (BVDV) virus-like particle vaccine candidates presenting the E2 protein using the SpyTag/SpyCatcher system induce a robust neutralizing antibody response in miceArchives of Virology, 2023
- Reactogenicity Following Receipt of mRNA-Based COVID-19 VaccinesJAMA, 2021
- BNT162b2 mRNA COVID-19 Vaccine: First ApprovalDrugs, 2021
- A systematic worldwide review of the direct monetary losses in cattle due to bovine viral diarrhoea virus infectionThe Veterinary Journal, 2017
- Bovine viral diarrhea virus (BVDV) infections in pigsVeterinary Microbiology, 2013
- Efficacy of a BVDV subunit vaccine produced in alfalfa transgenic plantsVeterinary Immunology and Immunopathology, 2013
- Structure of a Pestivirus Envelope Glycoprotein E2 Clarifies Its Role in Cell EntryCell Reports, 2013
- Immunization with plasmid DNA encoding a truncated, secreted form of the bovine viral diarrhea virus E2 protein elicits strong humoral and cellular immune responsesVaccine, 2005
- Detection and Characterization of Pestivirus Contaminations in Human Live Viral VaccinesBiologicals, 2002
- Molecular characterization of positive-strand RNA viruses: pestiviruses and the porcine reproductive and respiratory syndrome virus (PRRSV)1993